Page 279 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 279

230    Part III  Immunologic Basis of Hematology


        Several cytokines are implicated in Th1 differentiation, but the two   IL-4 produced by mature Th2 cells acts in a positive feedback loop
        most  critical  are  interferon  γ  (IFN-γ)  and  IL-12.  IFN-γ  produced   to promote further Th2 cell differentiation in naive T cells as they
        by  innate  immune  cells  promotes  Th1  differentiation  by  activat-  encounter antigen. Th2-derived IL-4 also mediates IgE class switch-
        ing  signal  transducer  and  activator  of  transcription  1  (STAT1),  a   ing in B cells. Soluble IgE binds to and crosslinks its high-affinity
        key  signaling  molecule  that  regulates  T-bet,  one  of  the  signature   receptor FcεRI on basophils and mast cells, promoting production
        transcription  factors  associated  with  Th1  cells.  IL-12,  produced   of  histamine  and  serotonin  as  well  as  several  cytokines,  including
        by  activated  APCs  and  other  innate  immune  cells,  acts  through  a   IL-4,  IL-13,  and  TNF-α.  IL-5  produced  from  Th2  cells  recruits
        separate STAT4-dependent pathway to promote IFN-γ production.   eosinophils, whereas Th2-derived IL-13 promotes both the expulsion
        IL-12  also  signals  to  upregulate  its  own  receptor  and  the  IL-18   of  helminths  during  parasitic  infection  and  also  the  induction  of
        receptor,  thereby  allowing  IL-18  to  act  in  concert  with  IL-12  to   airway hypersensitivity.
        promote IFN-γ production, thus creating a “feedforward” cycle to   Th2 responses are critical for immunity against extracellular para-
        amplify the Th1 response.                             sites, but excessive Th2 responses are associated with the pathologic
           T-bet,  a  T-box  family  member,  is  the  key  transcription  factor   conditions  of  allergy  and  airway  hypersensitivity.  The  increase  in
        associated  with  Th1  differentiation  and  function.  T-bet-deficient   asthma  in  the  developed  world  has  been  linked  to  an  imbalance
        T  cells  are  defective  in  their  ability  to  differentiate  into Th1  cells   of Th subsets with skewing toward “Th2-ness” in the population.
        either  in  vitro  or  in  vivo,  and T-bet-deficient  mice  are  unable  to   Additional  work  is  necessary  to  more  firmly  establish  a  molecular
        control Leishmania major infection, a well-characterized intracellular   immunologic link to the epidemiology of these diseases.
        pathogen model that depends on the characteristic Th1 cytokines for
        pathogen clearance. Whereas T-bet is considered the “essential” factor
        that directs Th1 lineage determination, other transcription factors,   Th17 Cells
        such as Runx3 and Hlx, are important for optimal Th1 function.
           Once differentiated, Th1 effector cells are characterized by pro-  The original description of Th1 and Th2 cells, indicating that not
                                                                           +
        duction  of  proinflammatory  cytokines  such  as  IFN-γ  and  tumor   all  mature  CD4   T  cells  were  alike,  led  to  the  search  for  other
                                                                  +
        necrosis factor-α (TNF-α) that stimulate macrophages, NK cells, and   CD4  subsets. Studies exploring the role of IL-23 in experimental
            +
        CD8  T cells to promote pathogen clearance. It is clear, however, that   autoimmune disease models found IL-23 to be critical for the gen-
                                                                                          +
        Th1 function must be balanced. Evidence from both animal models   eration of an IL-17-producing CD4  T-cell population, designated
        and human patients indicates that overexuberant Th1 responses drive   Th17 cells. Extensive analyses of IL-17 and the cells that produce
        inflammatory conditions and may lead to tissue destruction.  this  cytokine  demonstrate  that  Th17  cells  are  important  for  the
                                                              control of extracellular bacterial and fungal infections. With excessive
                                                              activity, however, these cells also appear to play an important role in
        Th2 Cells                                             autoimmune  diseases  through  the  production  of  proinflammatory
                                                              cytokines, including IL-17A, IL-17F, IL-21, and IL-22.
        Th2 cells are critical for the immune response against extracellular   Although IL-23 is a key regulator of Th17 cells, the IL-23 receptor
                                                                                      +
        parasites, such as helminths, through production of IL-4, IL-5, and   is not expressed on naive CD4  cells and hence could not explain
        IL-13.  At  initial  sites  of  parasitic  infection,  epithelial  cells  of  the   the differentiation of cells into the Th17 subset. Subsequent studies
        target organs, including the skin, lungs, and intestines, and resident   demonstrated that the combination of transforming growth factor-β
        cells  of  the  innate  immune  system  sense  parasite-derived  products   (TGF-β) with either IL-16 or IL-21 induces Th17 differentiation.
        and  produce  Th2-inducing  cytokines,  including  thymic  stromal   The  cytokines  that  are  key  mediators  of Th17  differentiation  and
        lymphopoietin (TSLP), IL-4, IL-25, and IL-33. These cytokines then   survival,  including  IL-6,  IL-21,  and  IL-23,  all  activate  STAT3.
        act on innate immune cells, including basophils and DCs, as well as   The critical role of this STAT family member was demonstrated in
                         +
        directly on naive CD4  cells to promote Th2 differentiation.  murine studies, when its deletion abrogated the ability of T cells to
           Recent work has provided insight into how cytokine signaling,   undergo Th17 differentiation. In humans, the importance of STAT3
        particularly IL-4 signaling, promotes Th2 differentiation. Through   was  highlighted  when  it  was  identified  as  the  genetic  mutation
        interaction  with  its  receptor,  IL-4  activates  STAT6.  STAT6  plays   present in many patients with hyper-IgE syndrome (HIES, or Job
        a  vital  role  in  Th2  differentiation,  as  evidenced  by  the  profound   syndrome). HIES is a rare immunodeficiency syndrome characterized
        reduction  in  development  of  this  lineage  in  Stat6-deficient  mice.   by recurrent staphylococcal skin abscesses, elevated serum IgE, and
        STAT6 activation leads to its nuclear translocation and subsequent   pneumatocele-forming pneumonias. Patients with HIES with STAT3
        induction of the transcription factor GATA3, which, like T-bet for   mutations have an impaired ability to form Th17 cells, which may
        Th1 cells, is considered the master regulator of Th2 differentiation.   explain part of their immunodeficiency. STAT3 regulates expression
        GATA3 regulates Th2 cytokine production by binding and activating   of  many  cytokine  and  cytokine  receptor  genes  involved  in  Th17
        the “Th2 locus,” which includes the genes encoding IL-4, IL-5, and   generation  or  function,  including  IL-17A,  IL-17F,  IL-21,  IL-21R,
        IL-13. When GATA3 function is abrogated, Th2 differentiation is   and IL-23R.
        virtually absent both in vitro and in vivo. In mature differentiated   STAT3  is  also  important  for  induction  of  the  signature  Th17
        Th2 cells, GATA3 deficiency results in loss of IL-5 and IL-13 produc-  transcription factor ROR-γt, which is a member of the retinoic acid–
                                                                                                     +
        tion. GATA3 is both necessary and sufficient for Th2 differentiation   related orphan receptor (ROR) family. In naive CD4  cells, ROR-γt
        because forced expression either by retroviral constructs or transgenic   induces  IL-17  gene  transcription  and  promotes  expression  of  the
        expression  promotes Th2  differentiation  and  represses Th1  differ-  IL-23 receptor. Overexpression of ROR-γt induces Th17 differentia-
        entiation.  Repression  of Th1  development  occurs  at  least  partially   tion, but deficiency of ROR-γt only partially affects Th17 cells in
        through  GATA3-dependent  inhibition  of  STAT4,  thus  interfering   vivo because of expression of the related transcription factor ROR-α,
        with Ifng gene transcription.                         which is also expressed in T cells and is induced by IL-6/TGF-β in
           TCR  signal  strength  also  is  involved  in  determining  if  a  naive   a  STAT3-dependent  manner.  Cells  deficient  in  both  ROR-γt  and
        T  cell  will  differentiate  into  a  Th1  or  Th2  cell.  Studies  in  mice   ROR-α  lose  the  ability  to  undergo Th17  differentiation,  both  in
        using  altered  peptide  ligands  that  have  decreased  affinity  for  par-  vitro and in vivo.
        ticular TCRs and experiments using limiting doses of antigen have   Th17 cells are induced during the response to extracellular bacteria
        demonstrated that diminished TCR stimulation promotes Th2 cell   and fungi, including Klebsiella pneumoniae, Bacteroides species, and
        differentiation. Differences in costimulation also affect Th2 pathway   Candida albicans. Indeed, some patients with chronic mucocutaneous
        differentiation. Mice deficient  in  CD28  or  its ligand  have  a  more   candidiasis have been shown to have mutations in IL-17F and the
        pronounced defect in Th2 responses, suggesting that these molecules   IL-17 receptor genes. Excessive Th17 cell function also plays a role
        may play a greater role in promoting Th2 differentiation than Th1    in autoimmune diseases, such as rheumatoid arthritis, psoriasis, and
        differentiation.                                      Crohn  disease,  and  therapies  targeting  the  IL-17/IL-23  axis  have
   274   275   276   277   278   279   280   281   282   283   284